highly significantp < 0.001
Overall, the 28-day mortality rate was reduced by 17% using dexamethasone with a highly significant trend showing greatest benefit among those patients requiring ventilation (test for trend, p < 0.001) [ 5 ].
Overall, the 28-day mortality rate was reduced by 17% using dexamethasone with a highly significant trend showing greatest benefit among those patients requiring ventilation (test for trend, p < 0.001) [ 5 ].
Trials such as the SOLIDARITY and RECOVERY are ongoing, and first results were announced in favour of therapy with dexamethasone with a significant trend showing greatest benefit among those patients requiring ventilation.